Last Updated on January 6, 2024 by The Health Master
Serum Institute of India (SII) will start production of Sputnik vaccine at the company’s facilities in September, Russian Direct Investment Fund (RDIF) said today.
“The first batch of Sputnik vaccine is expected to be produced at SII’s facilities in September,” RDIF said in a statement.
The parties intend to produce over 300 million doses of the vaccine in India per year, it added.
“As part of the technical transfer process, SII has already received cell and vector samples from the Gamaleya Center. With their import approved by the Drug Controller General of India (DCGI), the cultivation process has begun,” RDIF said.
Latest Notifications: EC Act (Essential Commodities Act)
NPPA fixes retail prices of 11 formulations
NABL: List of NABL Accredited Testing Laboratories
Abbott launches C-19 Home Test Kit in India
FDC launches Favipiravir oral suspension
Alert: Various chemicals in Cosmetics: Must read
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
